INTRODUCTION:

In a variety of industries, such as food, cosmetics, medicines, and product manufacturing, formulation and development are crucial phases. From the first idea to the finished product, these procedures entail developing and improving items. Iterative procedures necessitate cooperation across several departments, such as marketing, regulatory affairs, and research and development¹. To guarantee a good conclusion, effective communication and project management are crucial. Pharmaceutical formulation is a multi-step process that combines the active component with all other ingredients while accounting for pH, solubility, polymorphism, and particle size to produce the final, functional pharmaceutical product. The benefits and drawbacks of the active pharmaceutical ingredients (API), practical thrills, associated interactions, and manufacturing method are the four essential components of an effective pharmaceutical formulation^2,3.

Objectives of Formulation Development:^3,4

· Creating a superior product and production process that reliably yields the intended product performance

· Developing a novel medication that is stable, safe, and, ideally, a best-seller.

· Determining the properties of the materials and process variables that affect the medication product's quality qualities.

Concept of current Good Manufacturing Practices (cGMP):

The US FDA implements the current Good Manufacturing Practice (cGMP) regulations. The steps that must be taken, the facilities or controls that must be used for the manufacturing, processing, packaging, or storage of a medication in order to guarantee that the drug meets the requirements of the act, is robust and distinct, and has the purportedly present qualities and purity⁵. The regulations guarantee that a product contains the specified components and strength and is safe to use. One element of quality assurance, "good manufacturing practice," guarantees that pharmaceuticals are regularly manufactured and handled to the standards of quality suitable for their intended purpose⁶.

1. Quality Assurance:

Quality Assurance (QA) is a word relevant in both manufacturing and service sectors, encompassing systematic procedures used to guarantee that the goods provided to consumers conform to the agreed-upon performance, design, reliability, and maintainability standards⁷.

2. Quality Control:

The term quality control (QC) is a collection of practices used to guarantee that a manufactured good or service satisfies the needs of the client or customer and conforms with established quality standards⁷.

3. Good Manufacturing Practices (GMP):

GMP is a comprehensive system that guarantees that products are manufactured and managed consistently in accordance with quality standards. Its goal is to lessen production-related risks associated with medications that cannot be entirely eliminated by assessing the final product⁸.

From the initial supplies and facilities to the equipment, employee education, and personal cleanliness, GMP covers every aspect of manufacturing.

Fig. 1. Good Manufacturing Practices⁸

cGMP Requirements:

Professional and Skilled Staff, Measures to prevent the degradation or contamination of raw, processed, and final materials include a quality system (change control, validation), buildings and facilities that are suitable for their intended use, and equipment that is suitable, hygienic, well-maintained, and calibrated. Producing Using in-process metrics to monitor performance variations, Labelling and packaging that are same and protective Laboratory controls include specimens, tests, and parameters⁹.

The Pharmaceutical Medication Product with Many Dosage Forms:

The inclusion of many dosage types is often how the formulation functions. The dosage form refers to the pharmaceutical medicinal product as it is marketed for use with a certain mix of active and inactive substances. It needs to have a specified form (capsule shell, for example) and be distributed into a specific dosage⁹. Several popular formulations include:

ü Tablets, capsules, and liquids: these forms provide precise dosage, convenient administration, and prolonged storage.

ü Transdermal patches: These reduce the need for frequent dosing by providing regulated medication release over time.

ü Inhalers: These devices efficiently administer medications to the respiratory system for ailments including asthma.

Formulation involves combining various materials to develop a product with specific desired characteristics. This process is widely used across industries such as pharmaceuticals, cosmetics, food, and chemicals. The formulation process begins with setting clear goals, including defining the product’s purpose, target market, and essential attributes like texture, appearance, taste, or therapeutic efficacy^10,11.

Fig. 2. Dosage Forms¹⁰

Ingredient Selection and Initial Development:

Once objectives are established, the next step is to select appropriate ingredients. These are chosen based on factors such as quality, availability, compatibility, and purity. After ingredient selection, formulation parameters including ratios, concentrations, and constraints are determined. Using these parameters, an initial prototype formulation is created, which serves as the basis for further development¹².

Testing, Optimization, and Stability:

The preliminary formulation undergoes thorough testing to evaluate its physical chemical, and sensory characteristics. Based on test outcomes, iterative adjustments are made to improve the formulation^13,14. This cycle of testing and refinement continues until the formulation meets all required standards. Stability testing is also conducted to assess the product’s shelf life and performance under various environmental conditions^15,16.

Scale-Up and Quality Assurance:

Once optimized, the formulation is scaled up for commercial production, ensuring consistency and cost-effectiveness at larger volumes. Quality control measures are established to ensure that every production batch meets predefined standards. Regulatory compliance is also ensured by aligning the formulation with industry guidelines and legal requirements^17,18.

Documentation, Validation, and Launch:

Comprehensive documentation—including ingredient specifications, batch records, and test results—is maintained throughout the process to support quality and regulatory audits. Final validation confirms the formulation's readiness for full-scale production. Once validated, manufacturing and marketing processes are initiated, including labeling, packaging, and promotional strategies^19,20.

Post-Marketing Surveillance:

Even after commercialization, ongoing monitoring is essential. Feedback is collected from consumers, and the product’s performance is continuously evaluated. If necessary, further improvements or modifications are made to enhance quality and user satisfaction²¹.

Fig. 3. Phases of Formulation Development⁸

Ingredient Selection and Initial Development:^13,22

Steps in Formulation Development:

· Identification and characterization of drug

· Excipients compatibility study

· Formulation development

· Formulation optimization

· Evaluation of formulation

· Stability study

1. Identification and characterization of drug:

Identification:

Determining the role and participation of a possible therapeutic target, such as a gene, protein, or nucleic acid, in the illness is the first stage in the drug identification process. Following drug identification, the molecular pathways that the drug targets are characterized. A medicine should be safe, effective, and able to be smoked. It should also satisfy all clinical and commercial standards. Concepts from genetics, biochemistry, molecular biology, biophysics, and other disciplines may serve as the basis for drug identification techniques^14,15.

Characterization:

Early pharmacological studies can provide a better understanding of the molecule's mode of action. Size, form, strength, weakness, applicability, toxicity, and biological activity are all further investigated for each new pharmacological molecule that shows promise as a treatment^7,23.

2. Excipients compatibility study:^{11, 21}

During production or storage, reactive functional groups found in excipients, or drug impurities, may react with other reactive functional groups in drug molecules. Excipient impurities thus react with active medicinal ingredients to produce drug-related impurities.

3. Formulation development:

The successful creation of a commercial therapeutic product is linked to the discovery of a unique medicinal element. To create an effective pharmaceutical formulation, the active pharmaceutical ingredient (API) and inert excipients must be combined^7,22.

4. Formulation optimization:

The business implements formulation optimization throughout the product design stage because it thinks this method helps close the gap between pharmaceutical product development and commercial manufacturing^9,23.

5. Evaluation of formulation:

The acquired data were used to construct the compressibility index and Hausner-ratio. To ascertain their mass and tapped density, several pre-formulation investigations could be required. After that, a post-formulation analysis was conducted to assess the tablet's friability, thickness, hardness, content uniformity, and weight variation^7,9.

6. Stability study:¹⁰

The ability of a medication or product to maintain identity, quality, and purity criteria over an extended period of time is known as stability.

SOP Handling:²⁴

Standard Operating Procedure, or SOP for short, is a thorough collection of detailed instructions developed by a company to help staff members carry out daily duties. These procedures are more than just written instructions; they are papers that provide employees with step-by-step directions for navigating repetitious and technical organizational processes. SOPs' major goals are to increase productivity, guarantee high-quality output, and preserve performance consistency while lowering misunderstandings and guaranteeing adherence to industry rules.

The aims of SOPs are as follows:^12,14

1. Ensuring reliable and superior results.

2. Putting in place a unified organizational structure for gathering similar monitoring information on dangerous materials.

3. Preserving quality assurance and control.

4. Offering instructions for precise and timely data gathering.

SOP Writing Style:

Standard Operating Procedures (SOPs) have to follow a clear, succinct, easy-to-read, and sequential style. Present tense and active voice should be used to convey information in an easy manner. SOPs ought to be succinct and easy to understand. Think about using a graphical or hierarchical approach for displaying lengthy processes with over ten phases and few decision points. Adding flowcharts to processes that need a lot of decisions might be beneficial^13,17. Along with accountability and traceability duties, every SOP should outline standards for document identification and control. This is accomplished by keeping a consistent format. It's critical to highlight cautions in SOPs and advise users to use cautious in particular situations. Steer clear of phrases like "may" or "if possible," as they suggest flexibility in certain situations^14,25.

CONCLUSION:

In conclusion, the research and formulation of pharmaceuticals is a complex and ever-changing process that is essential to the introduction of safe and efficient therapies into the market. Pharmaceutical businesses use a systematic approach that combines scientific knowledge, technological breakthroughs, and regulatory compliance to create novel formulations that address unmet medical needs and enhance patient outcomes. The success of pharmaceutical formulation and development depends on interdisciplinary cooperation amongst experts in engineering, chemistry, biology, and pharmacology. These teams work together to develop drug formulations that have the best stability, bioavailability, and therapeutic efficacy. Additionally, improvements in drug delivery methods like tailored distribution and nanotechnology result in better treatment outcomes and fewer side effects. Lastly, improving patient quality of life and addressing global health issues depend heavily on pharmaceutical formulation and development. The pharmaceutical industry will become more and more crucial in driving innovation, providing ground-breaking therapeutic treatments, and shaping the direction of healthcare as science and technology advance.

REFERENCES:

1. Chaurasia G. A review on pharmaceutical formulation studies in formulation and development of new drug molecules. Int J Pharm Sci Res. 2016; 7(6): 2313-2320.

2. Butler JM, Dressman JB, Amaral ME, et al. The Developability Classification System: Application of Biopharmaceutics Concept to Formulation Development. J Pharm Sci. 2016; 99(12): 4940-4954.

3. Ravi Kumar, Swati Patil, MB Patil, Mahesh S Paschapur, Sachin R Patil. Formulation and Evaluation of Captopril Fast Dissolving Tablets by WOW Tab and Effervescent Technologies. Research J. Science and Tech. 2009; 1(1): 29-32

4. V.V. Nageswara Rao, K.V. Ramana Murthy. Formulation and Evaluation of Modified Pulsincap Technique for Oral Controlled Release of Glipizide. Research J. Science and Tech. 2012; 4(1): 9-12.

5. Deepak Patel, Sunil Kumar Shah, Chandra Kishore Tyagi. Design, Formulation and Characterization of Microspheres containing Mesalamine for the Treatment of Ulcerative Colitis. Research Journal of Science and Technology. 2021; 13(3):165-9.

6. Kapil Rana, Pushpendra Sharma. Analytical Method Development and Validation for the Simultaneous Estimation of Metformin Hydrochloride and Alogliptin by RP-HPLC in Bulk and Tablet Dosage Forms. Research Journal of Science and Technology. 2021; 13(2):111-8.

7. Salminen WF, McDuffie JE, White TE, et al. Streamlining nonclinical drug development using the FDA 505(b)(2) NDA regulatory pathway. J Pharm Sci. 2018; 10(9): 2212-2215.

8. Jameel F, Hershenson S. Formulation and process development strategies for manufacturing biopharmaceuticals. Hoboken, NJ: John Wiley & Sons. 2010: 2581-9429.

9. Jansche G, Cunningham S, Derouin K, et al. Biopharmaceutical processing: development, design, and implementation of manufacturing process. Amsterdam: Elsevier. 2018; 7(6): 2313-2320.

10. O’Connor T, Lee S. Emerging technology for modernizing pharmaceutical production: continuous manufacturing. In: Developing Solid and Oral Dosage Forms. 2nd ed. Amsterdam: Elsevier. 2017. 1031-1046.

11. S. D. Mankar, Anjali Dama, M. S. Bhosale, S. S. Sidhheshwar. Design, Development, Characterization of Solid Lipid Nanoparticles for Oral Administration. Research J. Science and Tech. 2020; 12(1):79-95.

12. S. D. Mankar, Anjali Dama, M. S. Bhosale, S. S. Sidhheshwar. Design, Development, Characterization of Solid Lipid Nanoparticles for Oral Administration. Research J. Science and Tech. 2020; 12(1):79-95.

13. Rowland M, Note CR. Impact of the pharmaceutical sciences on health care: a reflection over the past 50 years. J Pharm Sci. 2012; 101(11): 4075-4099.

14. Krylova OV, Litvinova TM. History of the paste-based drug formulation development. J Pharm Sci Res. 2018; 10(9): 2212-2215.

15. Dhananjay R. Chavhan, Kaveri K. Chaudhari. Development and assessment of antifungal and antibacterial Herbal Tablets using Trachyspermum ammi. Research Journal of Science and Technology. 2025; 17(2): 162-6.

16. Harsh H. Ladm, Ashvinkumar V. Dudhrejiya. Stability Indicating Method for Simultaneously Estimation of Teneligliptin, Pioglitazone and Metformin Hydrochloride in Combined Tablet Dosage form by RP-HPLC. Research Journal of Science and Technology. 2025; 17(2):101-8.

17. Shaikh AC, Shaikh SS, Shaikh AM, Gaikwad MS, Shinde PB. Review – Formulation Development Studies. Int J Creat Res Thoughts. 2022; 10(3); 2320-2882.

18. Akash Shelke, Someshwar Mankar, Mahesh Kolhe. A Review on Analytical Methods for estimation of Apremelast in Bulk, Pharmaceutical Formulation and in Biological Samples. Research Journal of Science and Technology. 2021; 13(2): 142-6.

19. Jadhav AB, Khamkar SP. Review on Formulation Development of Diclofenac Sodium. Int J Res Publ Rev. 2023; 4(3): 2043-2047.

20. Anuja Uddhav Deokar, Suhas Siddheshwar, Sudarshan. B. Kakad. Analytical Method Development and Validation of Rivaroxaban- A Review. Research J. Science and Tech. 2020; 12(1):36-46.

21. Chaurasia G. A review on pharmaceutical preformulation studies in formulation and development of new drug molecules. Int J Pharm Sci Res. 2016; 7(6): 2313-2320.

22. Kumar V, Bala R, Gill NS. A Comprehensive Review on Tablet Coating. J Pharm Sci Res. 2019; 11(6): 2148-2153.

23. Surve AD, Kaware AS, Chaudhari AS, Rajguru AG, Dwivedi AK. Review on Capsule Filling Machines. Int J Adv Res Sci Commun Technol. 2023; 3(2): 2581-9429.

24. Vishakha Shingote, S. D. Mankar, S. B. Dighe. A Review Article on Analytical Methods Development and Validation. Research Journal of Science and Technology. 2022; 14(1):77-3.

25. Raosaheb AP, Vinayak TG, Anil PG, Dattatray PV, Vilas CA. Review on Preformulation Studies. Int J Creat Res Thoughts. 2020; 11(9); 2320-2882.

Received on 17.04.2025 Revised on 26.05.2025

Accepted on 30.06.2025 Published on 08.08.2025

Available online from August 14, 2025

Research J. Science and Tech. 2025; 17(3):225-230.

DOI: 10.52711/2349-2988.2025.00031

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.